Amarin Corp Plcuk (AMRN) EBT Margin (2013 - 2026)

Amarin Corp Plcuk (AMRN) posted quarterly EBT Margin of 19.33% for Q1 2026, up 1311.0% YoY from 1.37% in Q1 2025, and down 1016.54% sequentially from 1.73% in Q4 2025.

Amarin Corp Plcuk (AMRN) EBT Margin (2013 - 2026) Analysis & Trends

Amarin Corp Plcuk has disclosed EBT Margin across 14 years of filings, most recently posting 19.33% for Q1 2026.

  • In Q1 2026, EBT Margin rose 1311.0% year-over-year to 19.33%; the TTM figure through Mar 2026 stood at 14.37% (down 958.0% YoY), while the FY2025 annual figure was 16.87%, down 1456.0% from the prior year.
  • EBT Margin fell to 19.33% in Q1 2026, from 1.73% in the prior quarter.
  • Over the last five years, EBT Margin for AMRN reached as high as 113.46% in Q4 2022 and fell as low as 68.61% in Q2 2022.
  • The 5-year median for EBT Margin is 16.86% (2023), against an average of 10.31%.
  • Annual changes were most pronounced in 2022 — EBT Margin jumped 10211 bps — and 2023, when it plunged 11674 bps.
  • A 5-year view of EBT Margin shows it stood at 113.46% in 2022, then slumped by 103 bps to 3.28% in 2023, then jumped by 1178 bps to 35.32% in 2024, then sank by 105 bps to 1.73% in 2025, then slumped by 1017 bps to 19.33% in 2026.
  • According to Business Quant data, EBT Margin over the past three periods registered 19.33%, 1.73%, and 16.34% for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 44.70%
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 24.89%
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 6.93%
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 27.21%
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -21.49%
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 24.18%
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 37.07%
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 135.53%
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn -19.33%

Historic Data

Download Data
DateValue
Mar 31, 2026 -19.33%
Dec 31, 2025 -1.73%
Sep 30, 2025 -16.34%
Jun 30, 2025 -18.49%
Mar 31, 2025 -32.44%
Dec 31, 2024 35.32%
Sep 30, 2024 -50.90%
Jun 30, 2024 4.29%
Mar 31, 2024 -15.31%
Dec 31, 2023 -3.28%
Sep 30, 2023 -28.48%
Jun 30, 2023 -22.35%
Mar 31, 2023 -16.86%
Dec 31, 2022 113.46%
Sep 30, 2022 -4.32%
Jun 30, 2022 -68.61%
Mar 31, 2022 -29.96%
Dec 31, 2021 11.35%
Sep 30, 2021 -9.13%
Jun 30, 2021 5.74%